News Image

Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

Provided By GlobeNewswire

Last update: Jun 25, 2024

The pooled analysis included data from 4 international clinical trials spanning an array of hard-to-treat indications including skin, head & neck, and oral cavity.

Read more at globenewswire.com

ALPHA TAU MEDICAL LTD

NASDAQ:DRTS (5/30/2025, 8:00:01 PM)

2.985

-0.02 (-0.5%)


ALPHA TAU MEDICAL LTD -27

NASDAQ:DRTSW (5/30/2025, 8:00:01 PM)

0.21

-0.04 (-16%)



Find more stocks in the Stock Screener

Follow ChartMill for more